These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 6850570)
81. Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna). Tacchi AM; Schmähl D; Habs M Cancer Lett; 1984 Feb; 22(1):89-94. PubMed ID: 6421479 [TBL] [Abstract][Full Text] [Related]
82. Severity of promotion by sodium salts of succinic acid in rat urinary bladder carcinogenesis correlates with sodium ion concentration under conditions of equal urinary pH. Otoshi T; Iwata H; Yamamoto S; Murai T; Yamaguchi S; Matsui-Yuasa I; Otani S; Fukushima S Carcinogenesis; 1993 Nov; 14(11):2277-81. PubMed ID: 8242855 [TBL] [Abstract][Full Text] [Related]
83. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis. He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125 [TBL] [Abstract][Full Text] [Related]
84. Effect of feeding N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on mitotic activity of rat urinary-bladder epithelium. Tiltman AJ; Friedell GH J Natl Cancer Inst; 1972 Jan; 48(1):125-9. PubMed ID: 4652369 [No Abstract] [Full Text] [Related]
85. Effect of indomethacin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urinary tract carcinogenesis. Holmäng S; Cano M; Grenabo L; Hedelin H; Johansson SL Carcinogenesis; 1995 Jul; 16(7):1493-8. PubMed ID: 7614682 [TBL] [Abstract][Full Text] [Related]
86. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine. Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262 [TBL] [Abstract][Full Text] [Related]
87. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine. Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235 [TBL] [Abstract][Full Text] [Related]
88. Analysis of differentiation-associated proteins in rat bladder carcinogenesis. Ogawa K; Sun TT; Cohen SM Carcinogenesis; 1996 May; 17(5):961-5. PubMed ID: 8640944 [TBL] [Abstract][Full Text] [Related]
89. Effect of promoters on incidence of bladder cancer in experimental animal models. Hicks RM Environ Health Perspect; 1983 Apr; 50():37-49. PubMed ID: 6873029 [TBL] [Abstract][Full Text] [Related]
90. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Wang CY; Hayashida S; Pamukcu AM; Bryan GT Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818 [TBL] [Abstract][Full Text] [Related]
91. The effect of long-term administration of aspirin and sodium saccharin on the rat kidney. Johansson SL; Sakata T; Hasegawa R; Zenser TV; Davis BB; Cohen SM Toxicol Appl Pharmacol; 1986 Oct; 86(1):80-92. PubMed ID: 3764937 [TBL] [Abstract][Full Text] [Related]
92. The mode of carcinogenic action of saccharin. Clayson DB Cancer Lett; 1984 Mar; 22(2):119-23. PubMed ID: 6704945 [TBL] [Abstract][Full Text] [Related]
93. Induction of DNA synthesis by sodium phenobarbital, uracil, and sodium saccharin in urinary bladder of the F344 rat. Debiec-Rychter M; Wang CY Toxicol Appl Pharmacol; 1990 Sep; 105(2):345-9. PubMed ID: 2219125 [TBL] [Abstract][Full Text] [Related]
94. Correlation between induction of DNA fragmentation in urinary bladder cells from rats and humans and tissue-specific carcinogenic activity. Robbiano L; Carrozzino R; Bacigalupo M; Corbu C; Brambilla G Toxicology; 2002 Sep; 179(1-2):115-28. PubMed ID: 12204548 [TBL] [Abstract][Full Text] [Related]
95. Focal loss of alkaline phosphatase and increase of proliferation in preneoplastic areas of the rat urothelium after administration of n-butyl-n-(4-hydroxybutyl)-nitrosamine and n-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Kunze E; Schauer A; Krüsmann G Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Oct; 84(2):143-60. PubMed ID: 127442 [TBL] [Abstract][Full Text] [Related]
96. Tumor production in germ-free rats fed 5-nitrofurans. Wang CY; Croft WA; Bryan GT Cancer Lett; 1984 Jan; 21(3):303-8. PubMed ID: 6692348 [TBL] [Abstract][Full Text] [Related]
97. Induction of repair synthesis of DNA in primary cultures of rat urothelial cells by derivatives of the bladder carcinogen, N-n-butyl-N-(4-hydroxybutyl)nitrosamine. Wang CY; Zukowski K; Daniel DS; Irving CC Chem Biol Interact; 1985; 53(1-2):99-105. PubMed ID: 3995657 [TBL] [Abstract][Full Text] [Related]
98. Gamma glutamyl transpeptidase activity in rat urothelium treated with bladder carcinogens. Ozono S; Homma Y; Oyasu R Cancer Lett; 1985 Oct; 29(1):49-57. PubMed ID: 2415236 [TBL] [Abstract][Full Text] [Related]
99. Development of sarcomas in heterotopically transplanted rat urinary bladder unit exposed to glucuronic acid conjugate of N-hydroxy-4-aminobiphenyl. Hirao Y; Miyata Y; Hearn WL; Radomski JL; Oyasu R Cancer Lett; 1981 Feb; 11(4):309-13. PubMed ID: 7296524 [TBL] [Abstract][Full Text] [Related]
100. Evaluation of a new model to detect bladder carcinogens or co-carcinogens; results obtained with saccharin, cyclamate and cyclophosphamide. Hicks RM; Wakefield J; Chowaniec J Chem Biol Interact; 1975 Sep; 11(3):225-33. PubMed ID: 1157191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]